HYPOFRACTIONATED RADIOTHERAPY IN GLIOBLASTOMA MULTIFORME

HYPOFRACTIONATED RADIOTHERAPY IN GLIOBLASTOMA MULTIFORME

Purpose: The purpose of this study was to assess the outcomes in glioblastoma patients treated with hypofractionated radiotherapy. Materials and Methods: We reviewed all glioblastoma patients treated at our specialist cancer centre over 7 and a 1⁄2 years using hypofractionated radiotherapy (HRT) p...

Full description

Bibliographic Details
Main Authors:	Sadaf Usman, Samreen J Chaudry, Shahid Hameed, Kamran Hussain, Sumera Butt
Format:	Article
Language:	English
Published:	Shaukat Khanum Memorial Trust 2015-11-01
Series:	Journal of Cancer and Allied Specialties
Online Access:	http://journals.sfu.ca/jcas/index.php/jcas/article/view/31

Similar Items

HYPOFRACTIONATED RADIOTHERAPY PART OF MULTIMODALITY TREATMENT IN MULTICENTRIC GLIOBLASTOMA MULTIFORME: A CASE REPORT
by: Vanessa MOLDOVEANU, et al.
Published: (2018-12-01)

Short Course Hypofractionated Radiotherapy versus Conventional Radiotherapy for Poor Prognosis Glioblastoma Multiforme: A Randomised Controlled Trial
by: SUNIL CHOUDHARY, et al.
Published: (2019-03-01)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
by: Guixiang Liao, et al.
Published: (2019-10-01)

Hypofractionated High-Dose Irradiation with Positron Emission Tomography Data for the Treatment of Glioblastoma Multiforme
by: Kazuhiro Miwa, et al.
Published: (2014-01-01)

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience
by: Liangzhi Zhong, et al.
Published: (2019-06-01)

Hypofractionated Radiation Therapy with Temozolomide for Patients with Glioblastoma Multiforme Recursive Partitioning Analyzes Class V and VI
by: Fuzuli Tuğrul, et al.
Published: (2019-09-01)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
by: Aisling M. Glynn, et al.
Published: (2019-08-01)

Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01)

Regulation of Expression of Immune Checkpoints in Glioblastoma Multiforme by Chemotherapy and Radiotherapy
by: Yii Ching Ng, et al.
Published: (2019)

Hypofractionated radiotherapy for breast cancer
by: Haviland, J.S, et al.
Published: (2010)

Glioblastoma Multiforme
by: Jonas M. Sheehan, et al.
Published: (2012-01-01)

Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01)

Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
by: Jinyeong Choi, et al.
Published: (2020-09-01)

INFLUENCE OF PERITUMORAL EDEMA ON THE OUTCOME OF RADIOTHERAPY OF SUPRATENTORIAL NONCYSTIC GLIOBLASTOMA MULTIFORME
by: Ivan Stefanović, et al.
Published: (2011-09-01)

Changing Trends in Radiotherapy for Glioblastoma Multiforme and Effects on Normal Tissue Doses
by: Kamuran İbiş, et al.
Published: (2019-01-01)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
by: Georges Noël, et al.
Published: (2013-09-01)

Dosimetric and clinical results with volumetric modulated radiotherapy for glioblastoma multiforme: Our experience
by: Vanessa Gabriela Moldoveanu, et al.
Published: (2019-12-01)

Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01)

Cost Minimization Analysis of Hypofractionated Radiotherapy
by: Hannah L. Yaremko, et al.
Published: (2021-01-01)

Biomarkers of Glioblastoma Multiforme
by: Guru Dutta Satyarthee, et al.
Published: (2018-09-01)

Glioblastoma multiforme : An update
by: K I Mathai, et al.
Published: (2014-01-01)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
by: Shang-Yu Chou, et al.
Published: (2018-01-01)

The complement system in glioblastoma multiforme
by: T. A. M. Bouwens van der Vlis, et al.
Published: (2018-09-01)

Early toxicity of hypofractionated radiotherapy for prostate cancer
by: Pavel Krupa, et al.
Published: (2016-09-01)

Hypofractionated whole breast radiotherapy: current perspectives
by: Koulis TA, et al.
Published: (2015-10-01)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
by: L. Chinsoo Cho, et al.
Published: (2013-01-01)

Prion Protein in Glioblastoma Multiforme
by: Larisa Ryskalin, et al.
Published: (2019-10-01)

Correction: Fusion in Glioblastoma Multiforme.
Published: (2014-01-01)

Atypical Presentation of Glioblastoma Multiforme
by: Wissam Al-Janabi, et al.
Published: (2018-09-01)

Glioblastoma Multiforme Stem Cells
by: Irena Dimov, et al.
Published: (2011-01-01)

Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01)

Bilateral cystic glioblastoma multiforme
by: Sushil Kumar, et al.
Published: (2013-10-01)

Prognostic factors in glioblastoma multiforme
by: Leonardo Welling, et al.
Published: (2010-12-01)

The DNA methylome of glioblastoma multiforme
by: Ramon Martinez, et al.
Published: (2010-07-01)

Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01)

Current management of glioblastoma multiforme
by: Moscote-Salazar Luís Rafael, et al.
Published: (2010-12-01)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
by: Makoto Ohno, et al.
Published: (2019-11-01)

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
by: Carlo Greco
Published: (2013-09-01)

Hypofractionated radiotherapy has the potential for second cancer reduction
by: Besserer Jürgen, et al.
Published: (2010-02-01)

Cannot write session to /tmp/vufind_sessions/sess_qghnca36esh4ssvsegv797v1v9